Target intelligence / Profile preview

Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 (PCMTD2)

Target
PCMTD2
Molecular classification
Other (domain-containing protein; not a typical enzyme or receptor), Potential E3 ubiquitin ligase adaptor (via SOCS-box motifs)[2][3], Predicted protein-L-isoaspartate (D-aspartate) O-methyltransferase activity (disputed)[3]
01

Overview

Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 (PCMTD2) is a protein encoded by the PCMTD2 gene in humans. The protein contains domains homologous to the methyltransferase PCMT1, but it likely does not possess methyltransferase enzymatic activity under normal conditions. Instead, PCMTD2, similar to its paralog PCMTD1, features additional C-terminal domains containing SOCS-box motifs (BC-box and Cul-box) that suggest a role as a substrate adaptor for Cullin-RING E3 ubiquitin ligase complexes, such as ECS (Elongin BC-CUL5-SOCS-box). Through these motifs, PCMTD2 may be involved in recognizing isoaspartate-damaged proteins and targeting them for ubiquitylation and degradation, potentially contributing to cellular protein quality control. Additionally, PCMTD2 has been found to be essential for the survival of pro-B cells during V(D)J recombination, likely through a role in mitigating cellular stress from protein damage. There is currently no strong evidence that PCMTD2 is a direct therapeutic target, receptor, enzyme, or transporter, and its interactions with drugs or relevance as a biomarker are undocumented as of the most recent sources[2][3][4].

Other names
PCMTD2C20orf36FLJ10883protein-L-isoaspartate O-methyltransferase domain-containing protein 2
02

Biological functions

Protein binding[1][3]Predicted recognition of damaged proteins and involvement in their degradation via ubiquitylation[2][3]Protein damage response and repair (role in managing isoaspartyl damage, but no confirmed methyltransferase activity)[2][3]Essential for pro-B cell survival during V(D)J recombination by mitigating protein damage-induced stress[4]
03

Disease associations

Neurodevelopmental disorders (such as Houge-Janssens Syndrome 1, Autosomal Dominant Intellectual Developmental Disorder 13)[3]Possible link to protein homeostasis in development and stress responses[4]No strong or specific evidence for cancer, inflammation, neurodegeneration, or cardiovascular disease roles

Beyond the preview

Go deeper on Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 (PCMTD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein-L-isoaspartate O-methyltransferase domain-containing protein 2 (PCMTD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call